178 related articles for article (PubMed ID: 10469140)
21. Mechanism of plasminogen activator inhibitor-1 regulation by oncostatin M and interleukin-1 in human astrocytes.
Kasza A; Kiss DL; Gopalan S; Xu W; Rydel RE; Koj A; Kordula T
J Neurochem; 2002 Nov; 83(3):696-703. PubMed ID: 12390531
[TBL] [Abstract][Full Text] [Related]
22. Tumour necrosis factor alpha induces co-ordinated activation of rat GSH synthetic enzymes via nuclear factor kappaB and activator protein-1.
Yang H; Magilnick N; Ou X; Lu SC
Biochem J; 2005 Oct; 391(Pt 2):399-408. PubMed ID: 16011481
[TBL] [Abstract][Full Text] [Related]
23. Identification of novel NF-κB transcriptional targets in TNFα-treated HeLa and HepG2 cells.
Zhou F; Xu X; Wang D; Wu J; Wang J
Cell Biol Int; 2017 May; 41(5):555-569. PubMed ID: 28276104
[TBL] [Abstract][Full Text] [Related]
24. NF-kappa B site-mediated negative regulation of the HIV-1 promoter by CCAAT/enhancer binding proteins in brain-derived cells.
Mondal D; Alam J; Prakash O
J Mol Neurosci; 1994-1995; 5(4):241-58. PubMed ID: 7577367
[TBL] [Abstract][Full Text] [Related]
25. Southwestern blot mapping of potential regulatory proteins binding to the DNA encoding plasminogen activator inhibitor type 2.
Antalis TM; Godbolt D; Donnan KD; Stringer BW
Gene; 1993 Dec; 134(2):201-8. PubMed ID: 8262378
[TBL] [Abstract][Full Text] [Related]
26. Characterisation of PAUSE-1, a powerful silencer in the human plasminogen activator inhibitor type 2 gene promoter.
Ogbourne SM; Antalis TM
Nucleic Acids Res; 2001 Oct; 29(19):3919-27. PubMed ID: 11574673
[TBL] [Abstract][Full Text] [Related]
27. 1,25-Dihydroxyvitamin D₃ suppresses inflammation-induced expression of plasminogen activator inhibitor-1 by blocking nuclear factor-κB activation.
Chen Y; Kong J; Sun T; Li G; Szeto FL; Liu W; Deb DK; Wang Y; Zhao Q; Thadhani R; Li YC
Arch Biochem Biophys; 2011 Mar; 507(2):241-7. PubMed ID: 21176770
[TBL] [Abstract][Full Text] [Related]
28. Fc epsilonRI-mediated induction of TNF-alpha gene expression in the RBL-2H3 mast cell line: regulation by a novel NF-kappaB-like nuclear binding complex.
Pelletier C; Varin-Blank N; Rivera J; Iannascoli B; Marchand F; David B; Weyer A; Blank U
J Immunol; 1998 Nov; 161(9):4768-76. PubMed ID: 9794408
[TBL] [Abstract][Full Text] [Related]
29. Regulation of intercellular adhesion molecule-1 gene by tumor necrosis factor-alpha is mediated by the nuclear factor-kappaB heterodimers p65/p65 and p65/c-Rel in the absence of p50.
Aoudjit F; Brochu N; Bélanger B; Stratowa C; Hiscott J; Audette M
Cell Growth Differ; 1997 Mar; 8(3):335-42. PubMed ID: 9056676
[TBL] [Abstract][Full Text] [Related]
30. Antiparasitic treatment of patients with P. falciparum malaria reduces the ability of patient serum to induce tissue factor by decreasing NF-kappa B activation.
Bierhaus A; Hemmer CJ; Mackman N; Kutob R; Ziegler R; Dietrich M; Nawroth PP
Thromb Haemost; 1995 Jan; 73(1):39-48. PubMed ID: 7740494
[TBL] [Abstract][Full Text] [Related]
31. A labile repressor acts through the NFkB-like binding sites of the human urokinase gene.
Novak U; Cocks BG; Hamilton JA
Nucleic Acids Res; 1991 Jun; 19(12):3389-93. PubMed ID: 1905804
[TBL] [Abstract][Full Text] [Related]
32. Glucagon-like peptide-1 attenuates tumour necrosis factor-alpha-mediated induction of plasminogen [corrected] activator inhibitor-1 expression.
Liu H; Hu Y; Simpson RW; Dear AE
J Endocrinol; 2008 Jan; 196(1):57-65. PubMed ID: 18180317
[TBL] [Abstract][Full Text] [Related]
33. Transcriptional repression of interleukin-6 gene by adenoviral E1A proteins.
Janaswami PM; Kalvakolanu DV; Zhang Y; Sen GC
J Biol Chem; 1992 Dec; 267(34):24886-91. PubMed ID: 1332971
[TBL] [Abstract][Full Text] [Related]
34. Mechanism of glucocorticoid induction of the rat plasminogen activator inhibitor-1 gene in HTC rat hepatoma cells: identification of cis-acting regulatory elements.
Bruzdzinski CJ; Johnson MR; Goble CA; Winograd SS; Gelehrter TD
Mol Endocrinol; 1993 Sep; 7(9):1169-77. PubMed ID: 8247019
[TBL] [Abstract][Full Text] [Related]
35. Involvement of CCAAT/enhancer-binding protein and nuclear factor-kappa B binding sites in interleukin-6 promoter inhibition by estrogens.
Galien R; Evans HF; Garcia T
Mol Endocrinol; 1996 Jun; 10(6):713-22. PubMed ID: 8776731
[TBL] [Abstract][Full Text] [Related]
36. 1alpha,25-dihydroxyvitamin D3 and a variety of its natural metabolites transcriptionally repress nuclear-factor-kappaB-mediated interleukin-8 gene expression.
Harant H; Andrew PJ; Reddy GS; Foglar E; Lindley IJ
Eur J Biochem; 1997 Nov; 250(1):63-71. PubMed ID: 9431991
[TBL] [Abstract][Full Text] [Related]
37. Regulation of the human plasminogen activator inhibitor type 2 gene: cooperation of an upstream silencer and transactivator.
Stringer B; Udofa EA; Antalis TM
J Biol Chem; 2012 Mar; 287(13):10579-10589. PubMed ID: 22334683
[TBL] [Abstract][Full Text] [Related]
38. NF-kappaB and AP-1 are responsible for inducibility of the IL-6 promoter by ionizing radiation in HeLa cells.
Beetz A; Peter RU; Oppel T; Kaffenberger W; Rupec RA; Meyer M; van Beuningen D; Kind P; Messer G
Int J Radiat Biol; 2000 Nov; 76(11):1443-53. PubMed ID: 11098847
[TBL] [Abstract][Full Text] [Related]
39. Unique properties of a second human herpesvirus 8-encoded interferon regulatory factor (vIRF-2).
Burysek L; Yeow WS; Pitha PM
J Hum Virol; 1999; 2(1):19-32. PubMed ID: 10200596
[TBL] [Abstract][Full Text] [Related]
40. Anisodamine counteracts lipopolysaccharide-induced tissue factor and plasminogen activator inhibitor-1 expression in human endothelial cells: contribution of the NF-kappa b pathway.
Ruan QR; Zhang WJ; Hufnagl P; Kaun C; Binder BR; Wojta J
J Vasc Res; 2001; 38(1):13-9. PubMed ID: 11173990
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
